Canopy Growth Corporation (WEED.TO)
CAD 4.07
(-7.08%)
CAD 4.07
(-7.08%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 297.14 Million CAD | -26.25% |
| 2022 | 402.9 Million CAD | -22.57% |
| 2021 | 520.32 Million CAD | -4.82% |
| 2020 | 546.64 Million CAD | 37.08% |
| 2019 | 398.77 Million CAD | 76.18% |
| 2018 | 226.34 Million CAD | 190.37% |
| 2017 | 77.94 Million CAD | 95.38% |
| 2016 | 39.89 Million CAD | 214.16% |
| 2015 | 12.69 Million CAD | 1008.44% |
| 2014 | 1.14 Million CAD | 0.0% |
| 2013 | - CAD | -100.0% |
| 2012 | 4144.00 CAD | 0.0% |
| 2011 | - CAD | -100.0% |
| 2010 | 4488.00 CAD | 717.49% |
| 2009 | 549.00 CAD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 66.21 Million CAD | -9.03% |
| 2023 Q1 | 108.72 Million CAD | 24.21% |
| 2023 Q2 | 69.59 Million CAD | -35.99% |
| 2023 Q3 | 78.5 Million CAD | 12.8% |
| 2023 Q4 | 72.78 Million CAD | -7.28% |
| 2023 FY | 297.14 Million CAD | -26.25% |
| 2022 Q2 | 117.86 Million CAD | 7.04% |
| 2022 Q1 | 110.11 Million CAD | -1.48% |
| 2022 Q3 | 101.21 Million CAD | -14.13% |
| 2022 Q4 | 87.53 Million CAD | -13.51% |
| 2022 FY | 402.9 Million CAD | -22.57% |
| 2021 Q2 | 131.37 Million CAD | -3.55% |
| 2021 FY | 520.32 Million CAD | -4.82% |
| 2021 Q1 | 136.2 Million CAD | -8.24% |
| 2021 Q3 | 140.97 Million CAD | 7.31% |
| 2021 Q4 | 111.77 Million CAD | -20.71% |
| 2020 Q3 | 152.52 Million CAD | 12.76% |
| 2020 Q1 | 110.41 Million CAD | 2.32% |
| 2020 Q2 | 135.26 Million CAD | 22.51% |
| 2020 FY | 546.64 Million CAD | 37.08% |
| 2020 Q4 | 148.43 Million CAD | -2.68% |
| 2019 Q4 | 107.91 Million CAD | -12.81% |
| 2019 Q1 | 90.48 Million CAD | -3.79% |
| 2019 Q2 | 76.61 Million CAD | -15.33% |
| 2019 Q3 | 123.76 Million CAD | 61.54% |
| 2019 FY | 398.77 Million CAD | 76.18% |
| 2018 Q2 | 23.32 Million CAD | -9.99% |
| 2018 Q4 | 94.05 Million CAD | 13.25% |
| 2018 Q3 | 83.04 Million CAD | 256.02% |
| 2018 Q1 | 25.91 Million CAD | 13.64% |
| 2018 FY | 226.34 Million CAD | 190.37% |
| 2017 Q2 | 17.56 Million CAD | 10.68% |
| 2017 Q3 | 21.7 Million CAD | 23.51% |
| 2017 FY | 77.94 Million CAD | 95.38% |
| 2017 Q1 | 15.87 Million CAD | 8.27% |
| 2017 Q4 | 22.8 Million CAD | 5.1% |
| 2016 FY | 39.89 Million CAD | 214.16% |
| 2016 Q4 | 14.66 Million CAD | 50.34% |
| 2016 Q3 | 9.75 Million CAD | 14.76% |
| 2016 Q2 | 8.49 Million CAD | 21.68% |
| 2016 Q1 | 6.98 Million CAD | 38.52% |
| 2015 FY | 12.69 Million CAD | 1008.44% |
| 2015 Q3 | 3.48 Million CAD | 41.15% |
| 2015 Q4 | 5.04 Million CAD | 44.84% |
| 2015 Q2 | 2.46 Million CAD | 44.2% |
| 2015 Q1 | 1.71 Million CAD | 127.78% |
| 2014 Q4 | 750.8 Thousand CAD | 17.07% |
| 2014 FY | 1.14 Million CAD | 0.0% |
| 2014 Q1 | 188.73 Thousand CAD | 0.0% |
| 2014 Q3 | 641.3 Thousand CAD | 102.87% |
| 2014 Q2 | 316.11 Thousand CAD | 67.49% |
| 2013 Q4 | - CAD | -100.0% |
| 2013 FY | - CAD | -100.0% |
| 2013 Q1 | 998.00 CAD | 3.42% |
| 2013 Q2 | 997.00 CAD | -0.1% |
| 2013 Q3 | 48.00 CAD | -95.19% |
| 2012 Q3 | 1002.00 CAD | 0.0% |
| 2012 FY | 4144.00 CAD | 0.0% |
| 2012 Q2 | - CAD | 0.0% |
| 2012 Q4 | 965.00 CAD | -3.69% |
| 2012 Q1 | - CAD | 0.0% |
| 2011 Q3 | 1185.00 CAD | -4.97% |
| 2011 Q1 | 1247.00 CAD | 3.31% |
| 2011 Q2 | 1247.00 CAD | 0.0% |
| 2011 Q4 | - CAD | -100.0% |
| 2011 FY | - CAD | -100.0% |
| 2010 Q1 | 549.00 CAD | 0.0% |
| 2010 Q4 | 1207.00 CAD | -18.72% |
| 2010 FY | 4488.00 CAD | 717.49% |
| 2010 Q3 | 1485.00 CAD | 0.0% |
| 2010 Q2 | - CAD | -100.0% |
| 2009 Q2 | - CAD | 0.0% |
| 2009 FY | 549.00 CAD | 0.0% |
| 2009 Q3 | - CAD | 0.0% |
| 2009 Q4 | - CAD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Aurora Cannabis Inc. | 270.28 Million CAD | -9.94% |
| Avicanna Inc. | 16.79 Million CAD | -1669.623% |
| Avant Brands Inc. | 26.34 Million CAD | -1027.946% |
| Cardiol Therapeutics Inc. | - CAD | -Infinity% |
| Crescita Therapeutics Inc. | 17.52 Million CAD | -1595.845% |
| Knight Therapeutics Inc. | 328.19 Million CAD | 9.462% |
| MediPharm Labs Corp. | 33.06 Million CAD | -798.754% |
| OrganiGram Holdings Inc. | 149.2 Million CAD | -99.153% |
| Willow Biosciences Inc. | 1.17 Million CAD | -25253.754% |
| Auxly Cannabis Group Inc. | 101.07 Million CAD | -193.977% |